What's happening
This bill requires hospitals to inform patients about all reconstructive options after mastectomy, including going breastless or flat.
Why it matters
Expands patient autonomy and informed consent. by explicitly requiring hospitals to tell patients about "going breastless or flat" (aesthetic flat closure), not just traditional breast reconstruction, so patients can make choices that best fit their values and preferences.
Recognizes and legitimizes non-reconstruction as a valid option. , addressing concerns that patients may feel pressured into reconstruction or may not even be told about flat closure as an equal alternative.
May reduce emotional distress and improve satisfaction. for patients who prefer no reconstruction, by ensuring they’re aware this is a supported, insurable, and medically recognized choice—potentially decreasing regret or surprise after surgery.
Could influence hospital protocols and clinician education,. ensuring that staff are informed about all reconstructive and non-reconstructive options, which may lead to more respectful, individualized patient care.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Patients undergoing mastectomy, lumpectomy or lymph node dissection
They would receive written information before consenting to surgery about going breastless or flat and aesthetic flat closure, including the advantages and disadvantages of these options.
General hospitals providing these surgeries
They would have to expand their required patient information to include going breastless or flat and aesthetic flat closure.
Breast and reconstructive surgeons
The required patient materials would describe aesthetic flat closure as reconstruction of the chest wall contour with no excess tissue.
Headline styles
Expand Breast Surgery Patient Rights
Plain English, a few words. Used as the page title.
Sponsors
1 Co-sponsor
History
- Referred to women's issues
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Require Cancer Surgery Options Disclosure
In Senate Committee · Women's Issues · Sponsor Chantel Jackson
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
8232
IN SENATE
February 7, 2022
Introduced by Sen. SALAZAR -- read twice and ordered printed, and when printed to be committed to the Committee on Women's Issues
AN ACT to amend the public health law, in relation to hospital care for mastectomy, lumpectomy, and lymph node dissection patients
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 2 of section 2803-o of the public health law, as added by chapter 354 of the laws of 2010, is amended to read as follows:
2. Every general hospital that provides mastectomy surgery, lymph node dissection or a lumpectomy shall provide information to the patient concerning the option of reconstructive surgery following such procedures, including the availability of coverage for reconstructive surgery, in accordance with the provisions of sections three thousand two hundred sixteen, three thousand two hundred twenty-one and four thousand three hundred three of the insurance law and applicable provisions of federal law. The information shall be provided to the patient in writing and in advance of obtaining consent to the surgical procedure. The information provided shall include at least the following:
(a) a description of the various reconstructive options and the advantages and disadvantages of each, including going breastless or flat and having an aesthetic flat closure, which is the reconstruction of the chest wall contour with no excess tissue;
(b) a description of the provisions assuring coverage by public and private insurance plans of the costs related to reconstructive surgery under federal and state law;
(c) a description of how a patient may access reconstructive care, including the potential of transferring care to a facility that provides reconstructive care or choosing to pursue reconstruction after completion of breast cancer surgery and chemo/radiotherapy, if warranted;
(d) such other information as may be required by the commissioner.
§ 2. This act shall take effect on the first of January next succeeding the date on which it shall have become a law.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD14118-01-1
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to hospital care for mastectomy, lumpectomy, and lymph node dissection patients
Purpose or general idea of bill
This bill requires that every general hospital that provides mastectomy surgery, lymph node dissection or a lumpectomy shall provide information to the patient concerning their options following such procedures.
Summary of provisions
Section 1. Subdivision 2 of section 2803-o of the public health law, as added by chapter 354 of the laws of 2010, is amended to include the option of an aesthetic flat closure or going flat, which is recon- struction of the chest wall contour with no excess tissue after a mastectomy.
Read the full memo (881 words)
Justification
The Centers for Disease Control indicates that breast cancer is the second most common cancer among women in the United States. Women should be armed with all the information they need to make the best decision for themselves and their bodies, this very personal decision should include the option of going breastless or going flat and obtaining an aesthetically pleasing outcome; an aesthetic flat closure.
A 2021 study released by the journal Annals of Surgical Oncology (1) indicates that more women are choosing to go flat and opt out of breast reconstruction after mastectomy surgery. The study further indicates that for many of those women their decision was not supported by their surgeon siting older studies indicating reconstruction provided a better quality of life option for women. In recent years, however, a growing number of women and advocacy groups have been outspoken about going breastless or "going flat" and the pushback received from breast surgeons who have pushed heavily towards reconstruction.
Women undergoing cancer treatment are dealing with enough trauma and having to also worry about their surgeon going against their treatment choice should not be part of their of their recovery journey. In many cases, surgeons who do a mastectomy with no reconstruction often leave extra skin in case the patient changes her mind and then decides to choose implants. However, this action adds stress and the need to obtain "revision surgery" to remove the excess skin; sometimes more than one revision surgery may be needed.
A woman's choice to go flat is very personal and can include wanting to avoid additional surgeries, feel comfortable with the idea of going flat, and even looking to avoid additional complications. In October 2021, the FDA strengthened the safety requirements for manufacturers requiring that patients are warned of possible complications from the use of breast implant.(2) This action by the FDA was a direct result of issues faced by thousands of women after receiving breast implants. Implants have been linked to a long list of side effects and exposure to cancer causing materials. The FDA's new requirement ensures patients are informed of all risks associated with using breast implants. The patient should be fully informed of all risks to allow them to make the best choice for themselves. Another issue faced by women who choose going flat is a surgeon's failure to provide an aesthetically pleasing outcome after surgery. This leads to more surgeries, which can be costly for patients who may have high copayments or may not be able to take time off from work. According to the recently recognized term by the National Cancer Institute, an "aesthetic flat closure is a type of surgery that is done to rebuild the shape of the chest wall after one or both breasts are removed. An aesthetic flat closure may also be done after removal of a breast implant that was used to restore breast shape. During an aesthetic flat closure, extra skin, fat, and other tissue in the breast area is removed. The remaining tissue is then tightened and smoothed out so that the chest wall appears flat."
Federal protections are already in place to ensure women undergoing breast cancer receive the care they need. The 1998 Women's Health and Cancer Rights Act is the federal law that provides protections to those who choose to have breast reconstruction in connection with a mastectomy(3). Coverage must be provided for: 1) all stages of recon- struction of the breast on which the mastectomy has been performed; 2) surgery and reconstruction of the other breast to produce a symmetrical appearance; and 3) prosthesis and treatment of physical complications of all stages of the mastectomy, including lymphedema.
This bill ensures breast cancer patients are informed of their choices, which include the option to go flat. As more women continue to opt to go flat, their decision should be respected by the medical professionals providing care during their breast cancer journey.
Prior legislative history
This is a new bill.
Fiscal implications
None.
Effective date
Effective immediately. (1) Baker, J.L., Dizon, D.S., Wenziger, C.M. et al. "Going Flat" After Mastectomy: Patient-Reported Outcomes by Online Survey. Ann Surg Oncol 28, 2493-2505 2021). HTTPS://DOI.ORG/10.1245/ S10434-020-09448-9 (2) October 27, 2021: FDA News Release: FDA Strengthens Safety Require- ments and Updates Study Results for Breast Implants. Agency adds restrictions and approves new labeling for all approved breast implants
HTTPS://WWW.FDA.GOV/NEWS-EVENTS/PRESS-ANNOUNCEMENTS/FDA- STRENGTHENS-SAFETY-REQUIREMENTS-AND-UPDATES-STUDYLRESULTS-BREAST- IMPLANTS (3) The U.S. Women's Health and Cancer Rights Act, also known as Janet's Law, signed into law on October 21, 1998 as part of the 1999
OMNIBUS BILL (PUB.L. 105-277 https://www.govinfo.gov/content/pkg/PLAW-105pub1277/html/ PLAW-105pub1277.htm
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.